Interview with Kate Lynch, CEO, Generic Medicines Industry Association (GMiA)
In trying to be an effective association and positively influence the environment for your members, what have been…
Generic Medicines Industry Association
Last updated: 13.02.2014
Address: PO Box 222, Pymble BC NSW 2073,Australia
Tel:
Company description
The Generic Medicines Industry Association (GMiA) is a representative body of generic medicine suppliers in Australia. Its members ensure that all Australians are offered the highest quality generic medicines in the world whilst providing affordable community health outcomes that benefit all Australians.
Products and services
The guiding principles of the members of GMiA are:
To support the long term sustainability of the PBS by ensuring the timely and cost effective provision of Generic Medicines to consumers.
To support the quality use of medicines (QUM) in partnership with other stakeholders.
To support the development of policies that facilitate timely access to Generic Medicines for all Australians.
To support the development of policies that promote the continued viability of a local manufacturing base for Generic Medicines (for domestic and export markets).
To encourage a high level of awareness and general knowledge of the safety, efficacy and appropriate interchangeability of Generic Medicines amongst Healthcare Professionals, Government and Consumers.
To support balanced intellectual property rights in the pharmaceutical sector that enable timely, cost effective access to Generic Medicines.
To enhance the accountability of Members by establishing a complaints handling mechanism that is both readily accessible and transparent.
To reduce actual and potential conflicts of interest between Members and Healthcare Professionals responsible for prescribing and dispensing prescription medicines by establishing an Educational Event reporting procedure with independent review.
Interviews
Interview with Di Ford, Executive Director, Generic Medicines Industry…
To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry…
Related
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully…
Australia / Growing Clinical Trials Even in Pandemic’s Wake
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of…
Opinion / The Powerful Impact of Taking a Patient-Centric Approach in an Evolving Health Landscape
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Interview with Mal Eutick, CEO, Phebra Australia
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Interview with Marisa Petersen, Managing Director, George Clinical, Australia
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Interview with Vlado Perkovich, Executive Director, The George Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
Interview with John Chalmers, Senior Director, The George Institute
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in…
Interview with Megan Fookes, Director, Rare Voices
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
Australia: Where Value Beats Cost
In some ways the Australian medicines industry is going through the same restructuring and challenges as the…
Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service…
Interview with Radek Sali, CEO, SWISSE
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After…
Interview with Albert Spanos, General Manager, Celgene Australia
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
